The impact of point-of-care testing for influenza A and B on patient flow and management in a medical assessment unit of a general hospital

[1]  A. V. van Gageldonk-Lafeber,et al.  Implementation of point-of-care testing and a temporary influenza ward in a Dutch hospital. , 2019, The Netherlands journal of medicine.

[2]  H. Kandil,et al.  Respiratory viral point of care testing (POCT) allows improved infection control and bed management during an influenza outbreak , 2018, Respiratory infections.

[3]  T. Blackmore,et al.  Point of care influenza testing using Alere-i Influenza A & B assay: a practical assessment , 2018, bioRxiv.

[4]  Yi-Wei Tang,et al.  Profile of the Alere i Influenza A & B assay: a pioneering molecular point-of-care test , 2018, Expert review of molecular diagnostics.

[5]  J. H. Chen,et al.  Evaluation of the molecular Xpert Xpress Flu/RSV assay vs. Alere i Influenza A & B assay for rapid detection of influenza viruses. , 2017, Diagnostic microbiology and infectious disease.

[6]  S. Young,et al.  Diagnostic accuracy of the real-time PCR cobas® Liat® Influenza A/B assay and the Alere i Influenza A&B NEAR isothermal nucleic acid amplification assay for the detection of influenza using adult nasopharyngeal specimens. , 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[7]  F. Nolte,et al.  Direct Comparison of Alere i and cobas Liat Influenza A and B Tests for Rapid Detection of Influenza Virus Infection , 2016, Journal of Clinical Microbiology.

[8]  L. Grohskopf,et al.  Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014. , 2013, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[9]  M. Fuentes-Ferrer,et al.  Evaluation of the Alere i Influenza A&B assay for rapid identification of influenza A and influenza B viruses. , 2016, Journal of medical microbiology.

[10]  S. Behillil,et al.  Prospective evaluation of the Alere i Influenza A&B nucleic acid amplification versus Xpert Flu/RSV. , 2016, Diagnostic microbiology and infectious disease.

[11]  M. Waris,et al.  Performance of the Alere i influenza A&B assay and mariPOC test for the rapid detection of influenza A and B viruses. , 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[12]  D. Dwyer,et al.  Detection of influenza A and B with the Alere™ i Influenza A & B: a novel isothermal nucleic acid amplification assay , 2015, Influenza and other respiratory viruses.

[13]  K. Chapin,et al.  Performance of the Molecular Alere i Influenza A&B Test Compared to That of the Xpert Flu A/B Assay , 2014, Journal of Clinical Microbiology.

[14]  R. Selvarangan,et al.  Evaluation of the Alere i Influenza A&B Nucleic Acid Amplification Test by Use of Respiratory Specimens Collected in Viral Transport Medium , 2014, Journal of Clinical Microbiology.

[15]  D. Cohen,et al.  Multicenter clinical evaluation of the novel Alere™ i Influenza A&B isothermal nucleic acid amplification test. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[16]  N. E. Babady,et al.  Evaluation of Alere i Influenza A&B for Rapid Detection of Influenza Viruses A and B , 2014, Journal of Clinical Microbiology.

[17]  Edward A Belongia,et al.  Comparison of Nasal and Nasopharyngeal Swabs for Influenza Detection in Adults , 2012, Clinical Medicine & Research.

[18]  J. Burke,et al.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship , 2007 .

[19]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[20]  Demichelis,et al.  Evaluation of the , 1992, Physical review. B, Condensed matter.